Baylor College of Medicine: Molecular Profiling of Meningioma Can Lead to Improved Prognosis and Therapy
February 03, 2022
February 03, 2022
HOUSTON, Texas, Feb. 3 (TNSJou) -- The Baylor College of Medicine issued the following news:
Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital continued their efforts to improve tumor prognostication.
The t . . .
Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital continued their efforts to improve tumor prognostication.
The t . . .